arrow
B

Bente Glintborg

University of Copenhagen
H指数:31
被引数:4,243

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The association between systemic inflammation as measured by calprotectin and autoantibody load in rheumatoid arthritis

通过钙卫蛋白测量的系统性炎症与类风湿关节炎中自身抗体负荷的关联

2026-10-030
OAAI
Drug concentrations and anti-drug antibodies in patients with arthritis treated with infliximab and adalimumab - comparison of three assays

类风湿关节炎患者使用英夫利昔单抗和阿达木单抗治疗时的药物浓度和抗药抗体水平——三种检测方法的比较

2026-09-040
OAAI
Site-specific articular response to TNF inhibitor in axial spondyloarthritis: a European cohort study

轴向脊柱关节炎中肿瘤坏死因子抑制剂对特定关节位点的反应:一项欧洲队列研究

2026-07-240
OAAI
Safety outcomes in 2132 Danish patients with inflammatory arthritis treated with biosimilar infliximab (GP1111) in routine care

使用生物类似药英夫利昔单抗(GP1111)进行常规治疗的情况下,2132名患有炎症性关节炎的丹麦患者的安全结局。

2025-12-230
OA
Defining Bath Ankylosing Spondylitis Disease Activity Index Cut-off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis

定义巴思强直性脊柱炎疾病活动指数(BASDAI)截断值,以评估欧洲多国轴性脊柱关节炎患者队列中的疾病活动状态。

2025-12-020
OAAI
Prevalence of Tick-borne Neoehrlichia mikurensis in Individuals Undergoing B-cell Depleting Therapy in Denmark: A Prospective Cohort Study 2023-2024

2023-2024年丹麦B细胞耗竭治疗个体中蜱传Neoehrlichia mikurensis的流行率:一项前瞻性队列研究

2025-09-170
OAAI
Cohort profile: Copenhagen Hospital Biobank-chronic inflammatory disease—inflammatory bowel disease (CHB-CID:IBD) genetic cohort

队列概要:哥本哈根医院生物库—慢性炎症性疾病—炎症性肠病(CHB-CID:IBD)遗传队列

2025-06-090
OAAI
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

欧洲各国在组织治疗银屑病关节炎和轴向脊柱关节炎患者方面的国家医疗体系存在差异。

2025-06-010
OAAI
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
2025-05-011
OAAI
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid Arthritis

识别甘氨酸与瓜氨酸基序对决定抗瓜氨酸蛋白抗体与HLA II类分子结合的影响:来自对6,900名斯堪的纳维亚类风湿关节炎患者自身抗体谱分析的研究启示

2025-04-300
OAAI
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased
2025-02-280
OAAI
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic

类风湿关节炎或银屑病关节炎患者的间质性肺病起始生物制剂和对照: 来自5个北欧的数据

2024-09-011
OA
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries
2024-08-190
OAAI
A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a Safety Checklist

生物和靶向合成疾病修饰抗风湿药物的禁忌症和特殊警告的系统概述: 建立一个框架来创建安全检查表

2024-07-161
PRE
CLINICAL AND LABORATORY EXAMINATIONS THE FIRST 3 MONTHS PREDICT REMISSION AT 6 AND 12 MONTHS; RESULTS FROM A COLLABORATIVE STUDY ON TWO NORWEGIAN COHORTS OF EARLY OR ESTABLISHED RHEUMATOID ARTHRITIS

临床和实验室检查:前3个月预测6个月和12个月的缓解情况;来自一项关于挪威两个早期或晚期类风湿关节炎队列的协作研究

2024-06-010
PRE
THE NATIONWIDE DANISH DANBIO REGISTRY FOR PATIENT CARE AND DECISION SUPPORT: IMPROVED MONITORING IN >25.000 PATIENTS WITH RHEUMATOID ARTHRITIS

全国丹麦丹比奥登记系统用于患者护理和决策支持:在超过25,000名类风湿关节炎患者中的监测改进

2024-06-010
PRE
PREDICTORS OF SECUKINUMAB TREATMENT RESPONSE AND CONTINUATION IN AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE EUROSPA RESEARCH COLLABORATION NETWORK

赛妥珠单抗治疗反应和持续性的预测因子:欧洲脊柱关节炎研究合作网络的结果

2024-06-010
PRE